Cary Street Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Sell
36,041
-434
-1% -$64.6K 0.13% 179
2026
Q1
$5.35M Sell
36,475
-139
-0.4% -$21.4K 0.13% 165
2025
Q4
$5.67M Sell
36,614
-273
-0.7% -$40.9K 0.14% 160
2025
Q3
$5.13M Sell
36,887
-5,066
-12% -$686K 0.13% 166
2025
Q2
$5.65M Buy
41,953
+16,073
+62% +$2.17M 0.16% 151
2025
Q1
$3.78M Sell
25,880
-1,859
-7% -$270K 0.12% 178
2024
Q4
$3.82M Buy
+27,739
New +$4.06M 0.12% 164

Other funds holding XLV

Cary Street Partners's XLV Position: Q2 2026 in Review

Cary Street Partners reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 1.2% in Q2 2026, selling an estimated $64.6K and leaving 36,041 shares worth $5.72M. The position accounts for 0.13% of the portfolio, ranked #179.

Cary Street Partners first reported a position in XLV in Q4 2024 and has held it in 7 quarters since. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Cary Street Partners held 36,041 shares of State Street Health Care Select Sector SPDR ETF worth $5.72M as of Q2 2026.
  • Cary Street Partners sold 434 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $64.6K.
  • State Street Health Care Select Sector SPDR ETF made up 0.13% of Cary Street Partners's portfolio in Q2 2026, its #179 holding.
  • Cary Street Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2024 and has held it in 7 quarters since.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.